Why does convalescent plasma therapy for severe COVID-19 show mixed success?
Treatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
Read moreTreatment modalities against the coronavirus disease 2019 (COVID-19) pandemic are limited in efficacy. This has led many centers to use
Read moreWhen SARS-CoV-2, the virus that causes COVID-19, infects a human cell, it quickly begins to replicate by seizing the cell’s
Read moreThe main protease of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enzyme implicated in the transcription and replication
Read moreResearchers based in India have demonstrated that horses inoculated with an inactivated dosage of severe acute respiratory syndrome coronavirus 2
Read moreA team of scientists from the United Kingdom recently conducted a large-scale screening of several membrane-bound and soluble host cell
Read moreThought LeadersDr. Jean-François RupprechtCentre National de la Recherche Scientifique (CNRS)Aix-Marseille University How could pooling SARS-CoV-2 tests help to detect future
Read moreResearchers at the University of Texas, USA, valtrex instructions have confirmed the specific mutation in the B.1.1.7 variant of severe
Read moreResearchers in the United States have computed genome-wide covariation within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to investigate interactions
Read moreAmong a large sample of coronavirus disease 2019 (COVID-19) patients, researchers found that a genetic variant – caused by an
Read moreResearchers in the United States and South Africa report that the NVX-CoV2373 vaccine from Novavax has proved effective at preventing
Read more